Evidence map›Paper›PMID 28617417›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.

Cecilia Giunta, Matthias Baumann, Christine Fauth, Uschi Lindert, Ebtesam M Abdalla, Angela F Brady, James Collins, Jahannaz Dastgir, Sandra Donkervoort, Neeti Ghali and 20 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Surgical management of progressive spinal deformities in FKBP14-associated Ehlers-Danlos syndrome: a case report and literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Review
  4. Collagen IV biosynthesis: Intracellular choreography of post-translational modifications.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  5. Article
  6. Clinical diagnosis of the monogenic Ehlers-Danlos syndromes.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  7. Article
  8. Cold Spring Harbor molecular case studies · 2023
    Article
  9. Review
  10. Article
  11. [Advances in studies on genetics of syndromes combining sensorineural hearing loss with scoliosis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  12. Article
  13. Article
  14. The Ehlers-Danlos syndromes.Nature reviews. Disease primers · 2020
    Review
  15. Bone Disease in Patients with Ehlers-Danlos Syndromes.Current osteoporosis reports · 2020
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Cecilia GiuntaConnective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.
Matthias BaumannDepartment of Pediatrics I, Pediatric Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Christine FauthDivision of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Uschi LindertConnective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.
Ebtesam M AbdallaHuman Genetics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Angela F BradyEhlers-Danlos Syndrome, National Diagnostic Service, Northwick Park and St. Mark's Hospitals, Harrow, UK.
James CollinsMercy Clinic Pediatric Neurology, Springfield, Missouri, and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Jahannaz DastgirPediatric Neurology, Goryeb Children's Hospital, Morristown, New Jersey, USA.
Sandra DonkervoortNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Neeti GhaliEhlers-Danlos Syndrome, National Diagnostic Service, Northwick Park and St. Mark's Hospitals, Harrow, UK.
Diana S JohnsonEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Ariana KariminejadKariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran.
Johannes KochDepartment of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
Marius KraenzlinMedical Faculty of the University of Basel, and Clinic for Endocrinology, Diabetes & Metabolism, University Hospital Basel, Basel, Switzerland.
Nayana LahiriSouth West Thames Regional Genetics Service, St. George's University Hospitals NHS Foundation Trust, UK.
Bernarda LozicDepartment of Pediatrics University Hospital Centre Split, Split, Croatia.
Adnan Y ManzurDubowitz Neuromuscular Centre, UCL Institute of Child Health, Great Ormond Street Hospital, London, UK.
Jenny E V MortonWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK.
Jacek PilchDepartment of Pediatric Neurology, Medical University of Silesia, Katowice, Poland.
Rebecca C PollittSheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Gudrun SchreiberDepartment of Pediatric Neurology, Children's Hospital, Kassel, Germany.
Nora L ShannonNottingham Clinical Genetics Service, Nottingham City Hospital, Nottingham, UK.
Glenda SobeyEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Anthony VandersteenMaritime Medical Genetics Service, IWK Health Centre, Halifax, Nova Scotia, Canada.
Fleur S van DijkEhlers-Danlos Syndrome, National Diagnostic Service, Northwick Park and St. Mark's Hospitals, Harrow, UK.
Martina Witsch-BaumgartnerDivision of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Johannes ZschockeDivision of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
F Michael PopeNorth West Thames Regional Genetics Service, Kennedy Galton Centre, London, UK.
Carsten G BönnemannNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Marianne RohrbachConnective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.

Funding

Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
6 · The paper itself

Abstract

PurposeIn 2012 we reported in six individuals a clinical condition almost indistinguishable from PLOD1-kyphoscoliotic Ehlers-Danlos syndrome (PLOD1-kEDS), caused by biallelic mutations in FKBP14, and characterized by progressive kyphoscoliosis, myopathy, and hearing loss in addition to connective tissue abnormalities such as joint hypermobility and hyperelastic skin. FKBP14 is an ER-resident protein belonging to the family of FK506-binding peptidyl-prolyl cis-trans isomerases (PPIases); it catalyzes the folding of type III collagen and interacts with type III, type VI, and type X collagens. Only nine affected individuals have been reported to date.MethodsWe report on a cohort of 17 individuals with FKBP14-kEDS and the follow-up of three previously reported patients, and provide an extensive overview of the disorder and its natural history based on clinical, biochemical, and molecular genetics data.ResultsBased on the frequency of the clinical features of 23 patients from the present and previous cohorts, we define major and minor features of FKBP14-kEDS. We show that myopathy is confirmed by histology and muscle imaging only in some patients, and that hearing impairment is predominantly sensorineural and may not be present in all individuals.ConclusionOur data further support the extensive clinical overlap with PLOD1-kEDS and show that vascular complications are rare manifestations of FKBP14-kEDS.

Indexed as

AllelesGenetic Association StudiesMutationPhenotypeChildChild, PreschoolChromosome MappingCohort StudiesDNA Mutational AnalysisEhlers-Danlos SyndromeFemaleHumansMagnetic Resonance AngiographyMagnetic Resonance ImagingMalePeptidylprolyl IsomeraseFKBP14 protein, humanPeptidylprolyl Isomerase

Identifiers

PMID28617417
PMCPMC5763155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.